Double Blind, Placebo-controlled, Study of the Safety, Tolerability and Pharmacokinetics of AIN457 in Rheumatoid Arthritis Patients
Clinical trial NCT00669942 · COMPLETED
Trial details
- NCT number
- NCT00669942
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2005-12-01
- Primary completion
- 2008-11-01
- Enrollment
- 104
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.